EQ (Equillium, Inc.) Company Total Assets
Equillium, Inc. develops immunological drugs by collaborating with leading biotech giants, as evidenced by the price action of total assets at the 35.54 level. Equillium, Inc. focuses on therapies for severe inflammatory processes and kidney pathologies. The business model relies on the active engagement of third-party laboratories for primary research, which minimizes risks when working with external contractors.
Comprehensive metric breakdowns and analytics for equilliumbio.com (EQ)
- stock price and consensus target price:
- business market valuation indicators:
- book capitalization data:
- debt and liquidity details:
- net income and valuation multiples indicators:
Fundamental valuation:EQ - Equillium Bio
The dynamics of total resources at Equillium, Inc. (EQ) determine its ability to withstand market volatility, which is critical when diversifying immunomodulator clinical trials in partnership with pharmaceutical behemoths. An analysis of balance sheet assets, reverse-calculated via ROA, reflects the actual asset base and capital management efficiency, allowing investors to assess long-term return potential and the overall financial stability of the business.
Main competitors
argenx.com - Aggregate Asset Value|BNTX (BioNTech) - Company Total Assets|Company Total Assets Abivax|Aggregate Company Assets ADMA Bio (ADMA)|PTGX (Protagonist Corp) - Aggregate Asset Value|Aggregate Company Assets Immunovant, Inc. IMVT|KNSA - Cumulative Company Assets|Grifols - Company Total Assets|ADPT - Company Total Assets|CLDX (Celldex) - Cumulative Company Assets|Aurinia Corp - Aggregate Asset Value|BCRX (BioCryst) - Company Total Assets|veratx.com (VERA) - Company Total Asset Base|Aggregate Company Assets Dianthus Therapeutics, Inc. (DNTH)|Cumulative Company Assets Pharvaris NV PHVS|Aggregate Company Assets abcellera.com ABCL|TRML - Cumulative Company Assets|PGEN: Cumulative Company Assets|PHAR - Company Total Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Total Business Assets UPB|ZBIO (Zenas Biopharma, Inc.) - Company Total Assets|Company Assets Immunome Bio IMNM|Company Total Assets GOSS|KALV - Company Assets|Aggregate Company Assets Septerna SEPN|Company Balance Sheet Assets Pieris Pharma|SVRA: Cumulative Company Assets|RIGL - Company Total Assets|ANAB: Company Total Assets|ATXS - Company Total Asset Base|Aggregate Company Assets enGene|Aggregate Company Assets RAPT|Aggregate Company Assets Aerovate Therapeutics Inc (JBIO)|Aggregate Company Assets ACRS (Aclaris Therapeutics, Inc)|Company Total Assets KYTX (Kyverna Therapeutics)|Company Total Asset Base tizianalifesciences.com (TLSA)|CABA: Cumulative Company Assets|VTYX - Company Total Assets|Theratechnologies Inc (THTX) - Aggregate Company Assets|Cumulative Company Assets Avalo Therapeutics Inc|Cumulative Company Assets ELDN|AGEN: Aggregate Asset Value|Company Total Assets CLYM|Company Total Asset Base Zura Bio Ltd|Aggregate Company Assets aTyr ATYR|ADAG: Total Business Assets|Ikena Oncology, Inc. - Company Total Assets|Shattuck Labs, Inc. (STTK) - Cumulative Company Assets|CNTB (connectbiopharm.com) - Cumulative Company Assets|IMUX - Company Total Asset Base|ATRA (Atara Biotherapeutics, Inc.) - Company Total Assets|Company Assets InflaRx GmbH IFRX|Aggregate Company Assets X4 Pharmaceuticals (XFOR)|adicetbio.com (ACET) - Company Balance Sheet Assets|Aggregate Company Assets Celularity CELU|INMB (INmune Bio Inc) - Total Asset Value of Company|Barinthus Bio - Company Total Assets|Aggregate Asset Value KZR (Kezar Life Sciences Inc)|SABS: Company Total Assets|akaritx.com (AKTX) - Company Total Assets|Aggregate Company Assets Enlivex Therapeutics Ltd|QTTB: Aggregate Asset Value|Aggregate Company Assets GeoVax Labs Inc (GOVX)|Cumulative Company Assets Edesa Biotech Corp EDSA|Company Total Assets IBIO (iBio, Inc.)|Company Total Assets Carisma Therapeutics Inc CARM|XTLB: Cumulative Company Assets|Aggregate Asset Value BOLT (Bolt Biotherapeutics)|HCWB: Company Total Assets|APVO - Company Total Asset Base|Aggregate Company Assets AIM ImmunoTech Inc.|Cumulative Company Assets Aditxt Corp (ADTX)|Aggregate Company Assets GRI Bio (GRI)|Cumulative Company Assets XORTX Therapeutics Inc XRTX|ReShape Lifesciences - Cumulative Company Assets|Company Total Assets Revelation Biosciences Corp REVB|INDP - Aggregate Company Assets|SCNI (scinai.com) - Total Business Assets|CALI: Company Total Assets|Company Assets Affimed N.V. (AFMD)|ALLK (Allakos Inc) - Company Total Assets|Company Assets HOOKIPA HOOK|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|iteostherapeutics.com (ITOS) - Company Balance Sheet Assets|Ocean Biomedical - Cumulative Company Assets|Company Total Assets TC BioPharm (Holdings) Plc TCBP|Third Harmonic Bio, Inc - Company Total Assets